(Q74596949)

English

Update on the U.S. Food and Drug Administration regulatory approach to over-the-counter cholesterol-lowering drugs

scientific article published on 01 April 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

review article

1 reference

stated in

Europe PubMed Central

title

Update on the U.S. Food and Drug Administration regulatory approach to over-the-counter cholesterol-lowering drugs (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

author name string

D G Orloff

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

language of work or name

English

0 references

publication date

1 April 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

published in

American Journal of Cardiology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

volume

81

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

issue

8A

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

page(s)

79F

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

Identifiers

DOI

10.1016/S0002-9149(98)00273-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 November 2019

PubMed publication ID

9604919

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9604919

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9604919%20AND%20SRC:MED&resulttype=core&format=json

(Q74596949)

Update on the U.S. Food and Drug Administration regulatory approach to over-the-counter cholesterol-lowering drugs

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)